REXULTI is not really approved with the treatment of individuals with dementia-related psychosis without agitation that may possibly transpire with dementia because of Alzheimer’s ailment. The good thing is, it seems that just because a patient encounters an intensive reaction to ketamine/esketamine does not necessarily suggest this will transpire again. https://margaretr900pgv9.wikiadvocate.com/user